Free Voters State Parliamentary Group visits Alzchem Group AG in Trostberg
Trostberg. On Thursday, January 9, 2025, the Alzchem Group welcomed the Free Voters state parliamentary group to its site in Trostberg, Upper Bavaria. As part of their closed-door meeting, the members of parliament showed great interest in getting to know the company and the current challenges facing the chemical industry in Germany first hand.
At the beginning, the CEO of the Alzchem Group, Andreas Niedermaier, presented the company's impressive development. He particularly emphasized the strategic success of being able to break away from the general downward trend in the chemical industry. The guests were given detailed insights into the company's innovative products and trend-setting projects in order to gain a better understanding of the needs and perspectives of the Alzchem Group and the industry as a whole.
In a subsequent discussion, around 60 members of parliament and Alzchem employees engaged in a lively dialogue. The focus was on topics such as state support, reducing bureaucracy and the growing attractiveness of an additional production site in the US market.
A central topic of the visit was the increasing migration of investments in the chemical industry. Andreas Niedermaier made it clear: “Germany is facing intense competition for investment. Every decision is examined very carefully today – will it be in Germany or in the USA?” External factors such as high electricity prices in Germany and the sometimes excessive regulation could ensure that investments are more likely to be made abroad in the future. The CEO explained: ”Energy costs here are sometimes three to four times as high as at our site in Sweden, for example.” The high electricity prices in Germany thus represent a competitive disadvantage in international comparison that can hardly be compensated for.
The state chairman of the Free Voters and deputy prime minister Hubert Aiwanger urgently appealed to politicians, the media and society to rethink in order to ensure the competitiveness of the chemical industry. He said the new federal government is called upon to take rapid measures to prevent further migration.
The visit ended with an impressive tour of the plant premises. During a bus tour through the production facilities, the members of parliament were able to get a first-hand look at the company's highly innovative processes. This visit marked the start of an important dialog that emphasizes the importance of the chemical industry for Germany as a business location and at the same time underscores the urgent need for action.
Contact
Sabine Sieber
Head of Corporate Communications & Investor Relations
Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany
About Alzchem
Alzchem is a globally active specialty chemicals company that is one of the market leaders in most of its fields of activity. Alzchem offers answers to various global developments such as climate change, population growth and increasing life expectancy. We deliver solutions through brands and products of the highest quality and through a sustainable vision to help shape global developments.
The company sees interesting growth prospects for itself in the areas of human and animal nutrition and agriculture in particular. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and creatine products can contribute to a healthy old age as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
Alzchem Group AG’s broad product range includes dietary supplements, precursors for PCR tests and pharmaceutical raw materials. These offerings are the company’s response to global trends and developments. Alzchem is ideally positioned in this respect and considers itself well prepared for an environmental future and global developments.
The company employs around 1,690 people at four production sites in Germany and a plant in Sweden, as well as three sales companies in the USA, China and England. Alzchem generated Group sales of EUR 540.6 million and EBITDA of EUR 81.4 million in 2023.